Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Personal FET in RIF Patients According to Histological Dating of Endometrial of Natural/ Hormone Replacement Cycle

NCT03312309
completednot_applicable

Transcriptomic Profile of Endometrium in Different Histological Dating of Natural Cycle

NCT03222830
completednot_applicable

Transcriptomic Profile of Endometrium in Different Histological Dating of Hormone Replacement Cycle

NCT03222882

Clinical Trials (3)

Showing 3 of 3 trials
NCT03312309Not Applicable

Personal FET in RIF Patients According to Histological Dating of Endometrial of Natural/ Hormone Replacement Cycle

Completed
NCT03222830Not Applicable

Transcriptomic Profile of Endometrium in Different Histological Dating of Natural Cycle

Completed
NCT03222882Not Applicable

Transcriptomic Profile of Endometrium in Different Histological Dating of Hormone Replacement Cycle

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3